Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Broadcom’s Margin Outlook Overshadows Record AI Revenue

Dieter Jaworski by Dieter Jaworski
December 27, 2025
in Analysis, Earnings, Nasdaq, Semiconductors, Tech & Software
0
Broadcom Stock
0
SHARES
37
VIEWS
Share on FacebookShare on Twitter

Despite posting record-breaking quarterly results in December, Broadcom saw nearly a fifth of its market value erased. The semiconductor and software giant is experiencing growth in artificial intelligence (AI) that outpaces most rivals, yet Wall Street has refocused the narrative: soaring revenue does not automatically translate to higher profitability. The shares currently trade around $350 as analysts debate mounting margin pressure.

Analyst Confidence Contrasts with Insider Sales

The market’s long-term outlook remains largely positive. Among 40 covering analysts, 34 maintain a “Buy” rating, with three suggesting a moderate purchase. Only three consider the stock fairly valued at current levels. The consensus price target sits between $456 and $465, implying potential upside of over 30%. Morgan Stanley has set a target of $462, while Truist Securities is even more bullish at $510.

This optimism persists despite a notable insider transaction. Chief Legal Officer Mark David Brazeal recently sold 38,281 shares for $12.54 million, at prices ranging from $322 to $345. The timing, following the company’s margin guidance, added to near-term investor unease.

A Record Quarter with a Crucial Caveat

Broadcom’s fiscal fourth-quarter 2025 results were formidable on the surface. Revenue reached $18.02 billion, a 28% year-over-year increase. Sales from AI chips surged 74% to $6.5 billion. CEO Hock Tan projected that AI revenue would double to $8.2 billion in the upcoming quarter.

However, the tone shifted during the post-earnings conference call. Management issued guidance that the gross margin for Q1 2026 could contract by approximately 100 basis points. The explanation cited a rising proportion of total sales coming from its AI segment.

Key Q4 2025 Financial Metrics:

Should investors sell immediately? Or is it worth buying Broadcom?

  • Revenue: $18.02 billion (+28%)
  • Adjusted Earnings Per Share: $1.95 (exceeded expectations)
  • Free Cash Flow: $7.5 billion (+36%)
  • AI Backlog: $73 billion for the next 18 months

System Sales: The Double-Edged Sword

The margin pressure stems from a fundamental shift in Broadcom’s sales model. The company is increasingly selling complete AI systems rather than just its proprietary chips. These systems integrate Broadcom semiconductors with third-party components like memory chips. While this approach dramatically boosts top-line revenue, it dilutes overall profitability because of the incorporated lower-margin parts. Market experts speculate that a significant portion of the $21 billion in orders from Anthropic likely involves such system sales, which form a considerable share of the total backlog.

CFO Kirsten Spears acknowledged the gross margin impact but emphasized that the operating margin should see only a modest decline. She noted that higher revenue would help absorb fixed costs. For Q1 2026, management forecasts revenue of $19.1 billion with an EBITDA margin of 67%, slightly below the 68% reported in the prior quarter.

Capital Returns and Competitive Landscape

Broadcom continues to reward shareholders, raising its quarterly dividend by 10% to $0.65 per share, payable in late December. The planned total dividend for 2026 is $2.60, marking the 15th consecutive annual increase. With free cash flow for fiscal 2025 nearing $27 billion, the company is reducing debt taken on for the VMware acquisition and continuing its share repurchase program. $7.55 billion remains available under the current $10 billion buyback authorization.

Competitively, Marvell Technology is gaining ground in the custom AI chip segment, with its data center revenue recently climbing 39%. Broadcom is focusing on Ethernet-based networking solutions for massive AI clusters. Its Tomahawk 6 switch, offering 102 terabits per second of bandwidth, is considered central as hyperscale customers scale their infrastructure from 100,000 to potentially one million GPUs.

Regulatory challenges persist. The European cloud association CISPE is contesting the EU’s clearance of the VMware takeover. Aggressive licensing changes for VMware products have also drawn scrutiny. Broadcom’s software segment, which includes VMware, contributed $6.9 billion in Q4 revenue, a 19% increase.

The Core Investment Dilemma: Growth vs. Profitability

Since the December sell-off, Broadcom’s stock has consolidated in a range between $340 and $365. The 50-day moving average is $362, while the 200-day average stands at $280. The company’s custom ASIC business now serves five major hyperscalers, with two additional customers in development. The pivotal question for investors remains whether the explosive growth in AI revenue can sustainably offset the compression in margins.

Ad

Broadcom Stock: Buy or Sell?! New Broadcom Analysis from March 25 delivers the answer:

The latest Broadcom figures speak for themselves: Urgent action needed for Broadcom investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Broadcom: Buy or sell? Read more here...

Tags: Broadcom
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
Next Post
Realty Income Stock

Realty Income Shares Pause Near Peak Levels

Pepsi Stock

Institutional Buyers See Opportunity in PepsiCo's Recent Stock Weakness

Rocket Lab USA Stock

Rocket Lab Shares Pull Back Following Record Rally

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com